- Home
- NAGE vs III Comparison
NAGE vs III Comparison
Compare NAGE & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | III |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.0M | 197.1M |
| IPO Year | 2010 | 2006 |
Fundamental Metrics
Financial Performance| Metric | NAGE | III |
|---|---|---|
| Price | $3.06 | $5.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.00 | $5.50 |
| AVG Volume (30 Days) | ★ 346.5K | 171.6K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.46% |
| EPS Growth | 81.82 | ★ 216.67 |
| EPS | 0.09 | ★ 0.12 |
| Revenue | $129,423,000.00 | ★ $192,745,000.00 |
| Revenue This Year | $16.51 | $3.85 |
| Revenue Next Year | $14.58 | $4.34 |
| P/E Ratio | ★ $33.44 | $43.92 |
| Revenue Growth | ★ 29.95 | 4.51 |
| 52 Week Low | $2.87 | $3.74 |
| 52 Week High | $10.05 | $6.45 |
Technical Indicators
Market Signals| Indicator | NAGE | III |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 59.14 |
| Support Level | $2.95 | $3.86 |
| Resistance Level | $3.61 | $5.40 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 48.94 | 65.56 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About III Information Services Group Inc.
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.